心房颤动患者华法林抗凝治疗的管理现状

被引:48
作者
吴楠 [1 ]
顾晴 [1 ]
关玉霞 [2 ]
李宾宾 [2 ]
机构
[1] 北京协和医院心内科
[2] 北京协和医院消化内科
关键词
心房颤动; 华法林; 抗凝药; 自我护理;
D O I
暂无
中图分类号
R541.75 [];
学科分类号
摘要
<正>心房颤动(下称房颤)是临床最为常见的持续性心律失常,其主要危害是缺血性脑卒中。由于房颤并发脑卒中具有发病率高、致残率高、致死率高和复发率高的特点,使得抗凝治疗成为房颤患者治疗策略的重中之重。临床上最常用的口服抗凝药物是华法林,它能够显著降低房颤患者缺血性脑卒中的发生率。但由于该药治疗安全窗窄,半衰期长,与食物药物的相互作用明显,抗凝治疗需在严密监测国际标
引用
收藏
页码:337 / 340
页数:4
相关论文
共 17 条
  • [11] Point-of-care testing in haemostasis
    Perry, David J.
    Fitzmaurice, David A.
    Kitchen, Steve
    Mackie, Ian J.
    Mallett, Sue
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (05) : 501 - 514
  • [12] Self-monitoring of oral anticoagulation
    Richardson, E
    [J]. LANCET, 2006, 367 (9508) : 412 - 412
  • [13] Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation[J] . International Journal of Cardiology . 2004 (1)
  • [14] Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Ansell Jack,Hirsh Jack,Hylek Elaine,Jacobson Alan,Crowther Mark,Palareti Gualtiero. Chest . 2008
  • [15] 中国首家抗凝门诊落地. 裘炯华. 医院经济报 . 2013
  • [16] 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. Camm A John,Lip Gregory Y H,De Caterina Raffaele,Savelieva Irene,Atar Dan,Hohnloser Stefan H,Hindricks Gerhard,Kirchhof Paulus. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arr
  • [17] 中国部分地区心房颤动住院病例回顾性调查
    戚文航
    [J]. 中华心血管病杂志, 2003, (12) : 36 - 39